<html>
<head>
<title>Targets & Indicators</title>
</head>
<body>
<h2><hr><center><font face="Arial">Health and Wellbeing</font></center><hr></h2>
<h1><center>Targets & Indicators</center></h1>
<hr>
<pr>
<h3>Target 3.1</h3>
<br>
<strong>REDUCE MATERNAL MORTALITY</strong>
</br>
By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births.
<ul>
<li>
Indicator 3.1.1
<ul>
<li>Maternal mortality ratio. The maternal mortality ratio refers to the number of women who die from pregnancy-related causes while pregnant or within 42 days of pregnancy termination per 100,000 live births.</li>
</ul>
</li>
<li>
Indicator 3.1.2
<ul>
<li>Percentage of births attended by personnel trained to give the necessary supervision, care, and advice to women during pregnancy, labour, and the postpartum period; to conduct deliveries on their own; and to care for newborns</li>
</ul>
</li>
</ul>
<br>
<h3>Target 3.2</h3>
<br>
<strong>END ALL PREVENTABLE DEATHS UNDER 5 YEARS OF AGE</strong>
</br>
By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under‑5 mortality to at least as low as 25 per 1,000 live births.
<ul>
<li>
Indicator 3.2.1
<ul>
<li>Under-5 mortality rate. The under-5 mortality rate measures the number of children per 1,000 live births who die before their fifth birthday.
</ul>
</li>
<li>
Indicator 3.2.2
<ul>
<li>Neonatal mortality rate. The neonatal mortality rate is defined as the share of newborns per 1,000 live births in a given year who die before reaching 28 days of age
</ul>
</li>
</ul>
<br>
<h3>Target 3.3</h3>
<br>
<strong>FIGHT COMMUNICABLE DISEASES</strong>
</br>
By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases.
<ul>
<li>
Indicator 3.3.1
<ul>
<li>Number of new HIV infections per 1,000 uninfected population
</ul>
</li>
<li>
Indicator 3.3.2
<ul>
<li>Tuberculosis per 100,000 population
</ul>
</li>
<li>
Indicator 3.3.3
<ul>
<li>Malaria incidence per 1,000 population
</ul>
</li>
<li>
Indicator 3.3.4
<ul>
<li> Hepatitis B incidence per 100,000 population
</ul>
</li>
<li>
Indicator 3.3.5
<ul>
<li>Number of people requiring interventions against neglected tropical disease
</ul>
</li>
</ul>
<br>
<h3>Target 3.4</h3>
<br>
<strong>REDUCE MORTALITY FROM NON-COMMUNICABLE DISEASES AND PROMOTE MENTAL HEALTH</strong>
</br>
By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
<ul>
<li>
Indicator 3.4.1
<ul>
<li>Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
</ul>
</li>
<li>
Indicator 3.4.2
<ul>
<li>Suicide mortality rate
</ul>
</li>
</ul>
<br>
<h3>Target 3.5</h3>
<br>
<strong>PREVENT AND TREAT SUBSTANCE ABUSE</strong>
</br>
Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol.
<ul>
<li>
Indicator 3.5.1
<ul>
<li>Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders
</ul>
</li>
<li>
Indicator 3.5.2
<ul>
<li>Harmful use of alcohol, defined according to the national context as alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcohol.
</ul>
</li>
</ul>
<br>
<h3>Target 3.6</h3>
<br>
<strong>REDUCE ROAD INJURIES AND DEATHS</strong>
</br>
By 2020, halve the number of global deaths and injuries from road traffic accidents.
<ul>
<li>
Indicator 3.6.1
<ul>
<li>Death rate due to road traffic injuries.
</ul>
</li>
</ul>
<br>
<h3>Target 3.7</h3>
<br>
<strong>UNIVERSAL ACCESS TO SEXUAL AND REPRODUCTIVE CARE, FAMILY PLANNING AND EDUCATION</strong>
</br>
By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes.
<ul>
<li>
Indicator 3.7.1
<ul>
<li>Percentage of married women ages 15–49 years whose need for family planning is satisfied with modern methods of contraception.
</ul>
</li>
<li>
Indicator 3.7.2
<ul>
<li>Adolescent birth rate (aged 10–14 years; aged 15–19 years) per 1,000 women in that age group.
</ul>
</li>
</ul>
<br>
<h3>Target 3.8</h3>
<br>
<strong>ACHIEVE UNIVERSAL HEALTH COVERAGE</strong>
</br>
Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.
<ul>
<li>
Indicator 3.8.1
<ul>
<li>Coverage of essential health services.
</ul>
</li>
<li>
Indicator 3.8.2
<ul>
<li>Proportion of population with large household expenditures on health as a share of total household expenditure or income
</ul>
</li>
</ul>
<br>
<h3>Target 3.9</h3>
<br>
<strong>REDUCE ILLNESSES AND DEATH FROM HAZARDOUS CHEMICALS AND POLLUTION</strong>
</br>
By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination.
<ul>
<li>
Indicator 3.9.1
<ul>
<li> Mortality rate attributed to the household (indoor) and ambient (outdoor) air pollution.
</ul>
</li>
<li>
Indicator 3.9.2
<ul>
<li>Mortality rate attributed to unsafe water, sanitation, and lack of hygiene.
</ul>
</li>
<li>
Indicator 3.9.3
<ul>
<li>Mortality rate attributed to unintentional poisoning.
</ul>
</li>
</ul>
<br>
<h3>Target 3.A</h3>
<br>
<strong>IMPLEMENT THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL</strong>
</br>
Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate
<ul>
<li>
Indicator 3.A.1
<ul>
<li>"age-standardized prevalence of current tobacco use among persons aged 15 years and older".
</ul>
</li>
</ul>
<br>
<h3>Target 3.B</h3>
<br>
<strong>SUPPORT RESEARCH, DEVELOPMENT AND UNIVERSAL ACCESS TO AFFORDABLE VACCINES AND MEDICINES</strong>
</br>
Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all.
<ul>
<li>
Indicator 3.B.1
<ul>
<li>Proportion of the target population covered by all vaccines included in their national program.
</ul>
</li>
<li>
Indicator 3.B.2
<ul>
<li>Total net official development assistance (ODA) to medical research and basic health sectors.
</ul>
</li>
<li>
Indicator 3.B.3
<ul>
<li>Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis.
</ul>
</li>
</ul>
<br>
<h3>Target 3.C</h3>
<br>
<strong>INCREASE HEALTH FINANCING AND SUPPORT HEALTH WORKFORCE IN DEVELOPING COUNTRIES</strong>
</br>
Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States.
<ul>
<li>
Indicator 3.C.1
<ul>
<li>Health worker density and distribution.
</ul>
</li>
</ul>
<br>
<h3>Target 3.D</h3>
<br>
<strong>IMPROVE EARLY WARNING SYSTEMS FOR GLOBAL HEALTH RISKS</strong>
</br>
Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks.
<ul>
<li>
Indicator 3.D.1
<ul>
<li> International Health Regulations (IHR) capacity and health emergency preparedness
</ul>
</li>
<li>
Indicator 3.D.2
<ul>
<li>Percentage of bloodstream infections due to selected antimicrobial resistant organisms.
</ul>
</li>
</ul>
<br>